National Institute of Mental Health Schizophrenia Collaborative Study

Description

In the NIMH Schizophrenia Collaborative Study, patients were randomized to receive one of four medications, either placebo or one of three different anti-psychotic drugs. The protocol indicated subjects were to then be evaluated at weeks 0, 1, 3, 6 to assess severity of illness; additionally some measurements were made at weeks 2, 4, and 5. The dataset was taken from mixor package which unfortunately is no longer on CRAN. This is a data frame with 1603 observations on the following 9 variables.

References